← Leaderboards
Udo Rudloff
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Preclinical Drug Development”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$269,140,071
- David Heimbrook · Leidos Biomedical Research, Inc.$152,095,766
- Randall J Bateman · Washington University$99,994,011
- Michael W Weiner · Northern California Institute Res &Educ$71,598,372
- Elizabeth A Thom · George Washington University$51,850,894
- Jaap Goudsmit · Janessen Vaccines And Prevention, Bv$49,332,195
Research focus
Preclinical Drug DevelopmentCellsMalignant Neoplasm Of PancreasTumorMalignant NeoplasmsPre-ClinicalCancer CellMediatingSmall MoleculeLaboratoriesInnovationSignal TransductionBaseDoseEnvironmentPhenotypeDrug DevelopmentNeoplasm MetastasisPancreasSolidPharmaceutical PreparationsImmuneOrganMacrophage
Grant awards (16)
Preclinical drug development in pancreatic cancer$2,113,368
ZIA · FY2025 · CA · contact PI
Preclinical drug development in pancreatic cancer$2,272,436
ZIA · FY2024 · CA · contact PI
Preclinical drug development in pancreatic cancer$2,528,211
ZIA · FY2023 · CA · contact PI
Preclinical drug development in pancreatic cancer$2,069,338
ZIA · FY2022 · CA · contact PI
Preclinical drug development in pancreatic cancer$1,962,634
ZIA · FY2021 · CA · contact PI
Preclinical drug development in pancreatic cancer$1,539,190
ZIA · FY2020 · CA · contact PI
Preclinical drug development in pancreatic cancer$1,356,844
ZIA · FY2019 · CA · contact PI
Preclinical drug development in pancreatic cancer$1,268,802
ZIA · FY2018 · CA · contact PI
Preclinical drug development in pancreatic cancer$1,140,440
ZIA · FY2017 · CA · contact PI
Preclinical drug development in pancreatic cancer$1,131,974
ZIA · FY2016 · CA · contact PI
Preclinical drug development in pancreatic cancer$1,238,641
ZIA · FY2015 · CA · contact PI
Preclinical drug development in pancreatic cancer$1,150,996
ZIA · FY2014 · CA · contact PI
Preclinical drug development in pancreatic cancer$1,089,780
ZIA · FY2013 · CA · contact PI
Preclinical drug development in pancreatic cancer$1,212,844
ZIA · FY2012 · CA · contact PI
Preclinical drug development in pancreas cancer$1,056,492
ZIA · FY2011 · CA · contact PI
Preclinical drug development in pancreas cancer$746,546
ZIA · FY2010 · CA · contact PI